Recast Therapy vs. Book Reading for Developmental Language Disorder
Trial Summary
What is the purpose of this trial?
Developmental Language Disorder (DLD) affects approximately seven percent of the population and is characterized by grammatical deficits that cascade into lifelong academic challenges and under-employment. Current treatments for DLD produce good outcomes under ideal, high intensity conditions or when parents have been trained to deliver therapy using intense coaching methods; however, current publicly funded service delivery systems and private-pay reimbursement models do not support treatment being delivered in this ideal fashion for children older than three. This project will examine alternative methods of delivering treatment that may be more feasible under typical conditions and will identify implementation barriers, with the goal of improving long-term outcomes for children with DLD. We hypothesize that feasibility and palatability will influence dose, which will in turn affect the overall language outcomes.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of Recast Therapy for Developmental Language Disorder?
Research shows that conversational recast treatment can help children with developmental language disorder improve their grammar skills. Studies found that children who repeated the correct forms of words during therapy showed better progress, suggesting that this method can be effective in enhancing language abilities.12345
Is Recast Therapy or Book Reading Therapy safe for children with developmental language disorder?
How does Recast Therapy differ from other treatments for developmental language disorder?
Recast Therapy is unique because it involves conversational recasting, where a child's incorrect speech is repeated back correctly in a natural conversation, helping them learn grammar more effectively. This approach is different from traditional methods as it tailors language input to the child's developmental level, allowing children with language impairments to learn grammatical structures as efficiently as their peers.23578
Eligibility Criteria
This trial is for children aged 4-9 with Developmental Language Disorder (DLD), primarily English-speaking, and without autism or significant sensory-motor or psychiatric disorders. They must have a DLD diagnosis confirmed by specific language tests, hearing within the typical range, and caregivers willing to participate in training.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Children receive recast therapy or illustrated syntax stories provided by clinicians or caregivers over a 10-week period
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Recast Therapy
- Syntax Stories
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Delaware
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
University of Maryland, College Park
Collaborator